Cargando…
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases
Type 2 diabetes is a risk factor for Alzheimer's disease and Parkinson's disease. Insulin signaling in the brains of people with Alzheimer's disease or Parkinson's disease is impaired. Preclinical studies of growth factors showed impressive neuroprotective effects. In animal mode...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281420/ https://www.ncbi.nlm.nih.gov/pubmed/25558231 http://dx.doi.org/10.4103/1673-5374.145342 |